Stephen Miller - Publications

Northwestern University, Evanston, IL 
Molecular Neuroscience, Neurobiology of Disease, Neuroimmunology

240 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Titus HE, Chen Y, Podojil JR, Robinson AP, Balabanov R, Popko B, Miller SD. Pre-clinical and Clinical Implications of "Inside-Out" vs. "Outside-In" Paradigms in Multiple Sclerosis Etiopathogenesis. Frontiers in Cellular Neuroscience. 14: 599717. PMID 33192332 DOI: 10.3389/fncel.2020.599717  0.64
2020 Saito E, Gurczynski SJ, Kramer KR, Wilke CA, Miller SD, Moore BB, Shea LD. Modulating lung immune cells by pulmonary delivery of antigen-specific nanoparticles to treat autoimmune disease. Science Advances. 6. PMID 33067238 DOI: 10.1126/sciadv.abc9317  0.56
2020 Morris AH, Hughes KR, Oakes RS, Cai MM, Miller SD, Irani DN, Shea LD. Engineered immunological niches to monitor disease activity and treatment efficacy in relapsing multiple sclerosis. Nature Communications. 11: 3871. PMID 32747712 DOI: 10.1038/s41467-020-17629-z  0.56
2020 Podojil JR, Glaser AP, Baker D, Courtois ET, Fantini D, Yu Y, Eaton V, Sivajothi S, Chiang M, Das A, McLaughlin KA, Robson P, Miller SD, Meeks JJ. Antibody targeting of B7-H4 enhances the immune response in urothelial carcinoma. Oncoimmunology. 9: 1744897. PMID 32363111 DOI: 10.1080/2162402X.2020.1744897  0.6
2020 Robinson AP, Zhang JZ, Titus HE, Karl M, Merzliakov M, Dorfman AR, Karlik S, Stewart MG, Watt RK, Facer BD, Facer JD, Christian ND, Ho KS, Hotchkin MT, Mortenson MG, ... ... Miller SD, et al. Nanocatalytic activity of clean-surfaced, faceted nanocrystalline gold enhances remyelination in animal models of multiple sclerosis. Scientific Reports. 10: 1936. PMID 32041968 DOI: 10.1038/s41598-020-58709-w  0.64
2020 Freitag TL, Podojil JR, Pearson RM, Fokta FJ, Sahl C, Messing M, Andersson LC, Leskinen K, Saavalainen P, Hoover LI, Huang K, Phippard D, Maleki S, King NJC, Shea LD, ... Miller SD, et al. Gliadin Nanoparticles Induce Immune Tolerance to Gliadin in Mouse Models of Celiac Disease. Gastroenterology. PMID 32032584 DOI: 10.1053/j.gastro.2020.01.045  0.72
2019 Saito E, Kuo R, Kramer KR, Gohel N, Giles DA, Moore BB, Miller SD, Shea LD. Design of biodegradable nanoparticles to modulate phenotypes of antigen-presenting cells for antigen-specific treatment of autoimmune disease. Biomaterials. 222: 119432. PMID 31480002 DOI: 10.1016/j.biomaterials.2019.119432  0.56
2019 Saito E, Kuo R, Pearson RM, Gohel N, Cheung B, King NJC, Miller SD, Shea LD. Designing drug-free biodegradable nanoparticles to modulate inflammatory monocytes and neutrophils for ameliorating inflammation. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 30822435 DOI: 10.1016/j.jconrel.2019.02.025  0.56
2019 Chen Y, Podojil JR, Kunjamma RB, Jones J, Weiner M, Lin W, Miller SD, Popko B. Sephin1, which prolongs the integrated stress response, is a promising therapeutic for multiple sclerosis. Brain : a Journal of Neurology. PMID 30657878 DOI: 10.1093/brain/awy322  0.6
2018 Pearson RM, Podojil JR, Shea LD, King NJ, Miller SD, Getts DR. OVERCOMING CHALLENGES IN TREATING AUTOIMMUNTITY: DEVELOPMENT OF tolerogenic immune-modifying nanoparticles. Nanomedicine : Nanotechnology, Biology, and Medicine. PMID 30352312 DOI: 10.1016/j.nano.2018.10.001  0.72
2018 Smarr CB, Miller SD. The Use of Biodegradable Nanoparticles for Tolerogenic Therapy of Allergic Inflammation. Methods in Molecular Biology (Clifton, N.J.). 1799: 353-358. PMID 29956163 DOI: 10.1007/978-1-4939-7896-0_25  1
2018 Podojil JR, Chiang MY, Ifergan I, Copeland R, Liu LN, Maloveste S, Langermann S, Liebenson D, Balabanov R, Chi H, Chen L, Vignali DAA, Miller SD. B7-H4 Modulates Regulatory CD4 T Cell Induction and Function via Ligation of a Semaphorin 3a/Plexin A4/Neuropilin-1 Complex. Journal of Immunology (Baltimore, Md. : 1950). PMID 29898965 DOI: 10.4049/jimmunol.1700811  0.6
2018 Xu D, Robinson AP, Ishii T, Duncan DS, Alden TD, Goings GE, Ifergan I, Podojil JR, Penaloza-MacMaster P, Kearney JA, Swanson GT, Miller SD, Koh S. Peripherally derived T regulatory and γδ T cells have opposing roles in the pathogenesis of intractable pediatric epilepsy. The Journal of Experimental Medicine. PMID 29487082 DOI: 10.1084/jem.20171285  0.92
2018 Glaser AP, Fantini D, Wang Y, Yu Y, Rimar KJ, Podojil JR, Miller SD, Meeks JJ. APOBEC-mediated mutagenesis in urothelial carcinoma is associated with improved survival, mutations in DNA damage response genes, and immune response. Oncotarget. 9: 4537-4548. PMID 29435122 DOI: 10.18632/oncotarget.23344  0.6
2018 Hecht I, Toporik A, Podojil JR, Vaknin I, Cojocaru G, Oren A, Aizman E, Liang SC, Leung L, Dicken Y, Novik A, Marbach-Bar N, Elmesmari A, Tange C, Gilmour A, ... ... Miller SD, et al. ILDR2 Is a Novel B7-like Protein That Negatively Regulates T Cell Responses. Journal of Immunology (Baltimore, Md. : 1950). PMID 29431694 DOI: 10.4049/jimmunol.1700325  0.6
2018 Podojil JR, Hecht I, Chiang MY, Vaknin I, Barbiro I, Novik A, Neria E, Rotman G, Miller SD. ILDR2-Fc Is a Novel Regulator of Immune Homeostasis and Inducer of Antigen-Specific Immune Tolerance. Journal of Immunology (Baltimore, Md. : 1950). PMID 29431690 DOI: 10.4049/jimmunol.1700326  0.6
2017 Prasad S, Neef T, Xu D, Podojil JR, Getts DR, Shea LD, Miller SD. Tolerogenic Ag-PLG nanoparticles induce tregs to suppress activated diabetogenic CD4 and CD8 T cells. Journal of Autoimmunity. PMID 29258717 DOI: 10.1016/j.jaut.2017.12.010  0.72
2017 Casey LM, Pearson RM, Hughes K, Liu J, Rose J, North MG, Wang L, Mei L, Miller SD, Shea LD. Conjugation of transforming growth factor beta to antigen-loaded poly(lactide-co-glycolide) nanoparticles enhances efficiency of antigen-specific tolerance. Bioconjugate Chemistry. PMID 29148731 DOI: 10.1021/acs.bioconjchem.7b00624  0.56
2017 Ifergan I, Davidson TS, Kebir H, Xu D, Palacios-Macapagal D, Cann J, Rodgers JM, Hunter ZN, Pittet CL, Beddow S, Jones CA, Prat A, Sleeman MA, Miller SD. Targeting the GM-CSF receptor for the treatment of CNS autoimmunity. Journal of Autoimmunity. PMID 28641926 DOI: 10.1016/j.jaut.2017.06.005  0.96
2017 Pearson RM, Casey LM, Hughes KR, Wang LZ, North MG, Getts DR, Miller SD, Shea LD. Controlled Delivery of Single or Multiple Antigens in Tolerogenic Nanoparticles Using Peptide-Polymer Bioconjugates. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 28479234 DOI: 10.1016/j.ymthe.2017.04.015  0.72
2017 Pearson RM, Casey LM, Hughes KR, Miller SD, Shea LD. In vivo reprogramming of immune cells: Technologies for induction of antigen-specific tolerance. Advanced Drug Delivery Reviews. PMID 28414079 DOI: 10.1016/j.addr.2017.04.005  0.56
2017 Kuo R, Saito E, Miller SD, Shea LD. Peptide-Conjugated Nanoparticles Reduce Positive Co-stimulatory Expression and T Cell Activity to Induce Tolerance. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 28408181 DOI: 10.1016/j.ymthe.2017.03.032  0.56
2017 Podojil JR, Miller SD. Potential targeting of B7-H4 for the treatment of cancer. Immunological Reviews. 276: 40-51. PMID 28258701 DOI: 10.1111/imr.12530  0.6
2016 Kang HK, Wang S, Dangi A, Zhang X, Singh A, Zhang L, Rosati JM, Suarez-Pinzon W, Deng X, Chen X, Thorp EB, Hering BJ, Miller SD, Luo X. Differential role of B cells and IL-17 versus IFN-γ during early and late rejection of pig islet xenografts in mice. Transplantation. PMID 27893617 DOI: 10.1097/TP.0000000000001489  0.32
2016 McCarthy DP, Yap JW, Harp CT, Song WK, Chen J, Pearson RM, Miller SD, Shea LD. An antigen-encapsulating nanoparticle platform for TH1/17 immune tolerance therapy. Nanomedicine : Nanotechnology, Biology, and Medicine. PMID 27720992 DOI: 10.1016/j.nano.2016.09.007  0.76
2016 Getts DR, Shea LD, Miller SD, King NJ. Harnessing Nanoparticles for Immune Modulation: (Trends in Immunology 36, 419-427; July 2016). Trends in Immunology. PMID 27614797 DOI: 10.1016/  0.72
2016 Smarr CB, Yap WT, Neef TP, Pearson RM, Hunter ZN, Ifergan I, Getts DR, Bryce PJ, Shea LD, Miller SD. Biodegradable antigen-associated PLG nanoparticles tolerize Th2-mediated allergic airway inflammation pre- and postsensitization. Proceedings of the National Academy of Sciences of the United States of America. PMID 27091976 DOI: 10.1073/pnas.1505782113  0.96
2016 Luo X, Miller SD, Shea LD. Immune Tolerance for Autoimmune Disease and Cell Transplantation. Annual Review of Biomedical Engineering. PMID 26928211 DOI: 10.1146/annurev-bioeng-110315-020137  0.96
2016 Ifergan I, Chen S, Zhang B, Miller SD. Cutting Edge: MicroRNA-223 Regulates Myeloid Dendritic Cell-Driven Th17 Responses in Experimental Autoimmune Encephalomyelitis. Journal of Immunology (Baltimore, Md. : 1950). PMID 26783338 DOI: 10.4049/jimmunol.1501965  0.96
2016 Winger RC, Harp CT, Chiang MY, Sullivan DP, Watson RL, Weber EW, Podojil JR, Miller SD, Muller WA. Cutting Edge: CD99 Is a Novel Therapeutic Target for Control of T Cell-Mediated Central Nervous System Autoimmune Disease. Journal of Immunology (Baltimore, Md. : 1950). PMID 26773145 DOI: 10.4049/jimmunol.1501634  0.32
2015 Traka M, Podojil JR, McCarthy DP, Miller SD, Popko B. Oligodendrocyte death results in immune-mediated CNS demyelination. Nature Neuroscience. PMID 26656646 DOI: 10.1038/nn.4193  0.76
2015 Hussien Y, Podojil JR, Robinson AP, Lee AS, Miller SD, Popko B. ER Chaperone BiP/GRP78 Is Required for Myelinating Cell Survival and Provides Protection during Experimental Autoimmune Encephalomyelitis. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 35: 15921-33. PMID 26631473 DOI: 10.1523/JNEUROSCI.0693-15.2015  0.64
2015 Robinson AP, Rodgers JM, Goings GE, Miller SD. Characterizing oligodendroglial populations in development and disease using flow cytometry. International Journal of Developmental Neuroscience : the Official Journal of the International Society For Developmental Neuroscience. 47: 51-2. PMID 26531467 DOI: 10.1016/j.ijdevneu.2015.04.145  0.96
2015 Hlavaty KA, McCarthy DP, Saito E, Yap WT, Miller SD, Shea LD. Tolerance induction using nanoparticles bearing HY peptides in bone marrow transplantation. Biomaterials. 76: 1-10. PMID 26513216 DOI: 10.1016/j.biomaterials.2015.10.041  0.96
2015 James RE, Hillis J, Adorján I, Gration B, Mundim MV, Iqbal AJ, Majumdar MM, Yates RL, Richards MM, Goings GE, DeLuca GC, Greaves DR, Miller SD, Szele FG. Loss of galectin-3 decreases the number of immune cells in the subventricular zone and restores proliferation in a viral model of multiple sclerosis. Glia. PMID 26337870 DOI: 10.1002/glia.22906  0.44
2015 Lawson BR, Gonzalez-Quintial R, Eleftheriadis T, Farrar MA, Miller SD, Sauer K, McGavern DB, Kono DH, Baccala R, Theofilopoulos AN. Interleukin-7 is required for CD4(+) T cell activation and autoimmune neuroinflammation. Clinical Immunology (Orlando, Fla.). 161: 260-269. PMID 26319414 DOI: 10.1016/j.clim.2015.08.007  0.96
2015 Chastain EM, Getts DR, Miller SD. Deficient Natural Killer Dendritic Cell Responses Underlay the Induction of Theiler's Virus-Induced Autoimmunity. Mbio. 6: e01175. PMID 26242630 DOI: 10.1128/mBio.01175-15  0.96
2015 Getts DR, Shea LD, Miller SD, King NJ. Harnessing nanoparticles for immune modulation. Trends in Immunology. 36: 419-27. PMID 26088391 DOI: 10.1016/  0.96
2015 Banisadr G, Podojil JR, Miller SD, Miller RJ. Pattern of CXCR7 Gene Expression in Mouse Brain Under Normal and Inflammatory Conditions. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology. PMID 25997895 DOI: 10.1007/s11481-015-9616-y  0.96
2015 Najm FJ, Madhavan M, Zaremba A, Shick E, Karl RT, Factor DC, Miller TE, Nevin ZS, Kantor C, Sargent A, Quick KL, Schlatzer DM, Tang H, Papoian R, Brimacombe KR, ... ... Miller SD, et al. Drug-based modulation of endogenous stem cells promotes functional remyelination in vivo. Nature. 522: 216-20. PMID 25896324 DOI: 10.1038/nature14335  0.96
2015 McCarthy DP, Bryant J, Galvin JP, Miller SD, Luo X. Tempering allorecognition to induce transplant tolerance with chemically modified apoptotic donor cells. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 15: 1475-83. PMID 25807873 DOI: 10.1111/ajt.13237  0.96
2015 Hlavaty KA, Luo X, Shea LD, Miller SD. Cellular and molecular targeting for nanotherapeutics in transplantation tolerance. Clinical Immunology (Orlando, Fla.). PMID 25805659 DOI: 10.1016/j.clim.2015.03.013  0.96
2015 Way SW, Podojil JR, Clayton BL, Zaremba A, Collins TL, Kunjamma RB, Robinson AP, Brugarolas P, Miller RH, Miller SD, Popko B. Pharmaceutical integrated stress response enhancement protects oligodendrocytes and provides a potential multiple sclerosis therapeutic. Nature Communications. 6: 6532. PMID 25766071 DOI: 10.1038/ncomms7532  0.96
2015 Rodgers JM, Robinson AP, Rosler ES, Lariosa-Willingham K, Persons RE, Dugas JC, Miller SD. IL-17A activates ERK1/2 and enhances differentiation of oligodendrocyte progenitor cells. Glia. 63: 768-79. PMID 25557204 DOI: 10.1002/glia.22783  0.96
2015 Wang S, Zhang X, Zhang L, Bryant J, Kheradmand T, Hering BJ, Miller SD, Luo X. Preemptive Tolerogenic Delivery of Donor Antigens for Permanent Allogeneic Islet Graft Protection. Cell Transplantation. 24: 1155-65. PMID 24759564 DOI: 10.3727/096368914X681027  0.32
2015 Smarr CB, Getts DR, Miller SD. Therapeutic Immune Tolerance Approaches for the Treatment of Allergic Disease Translational Immunology: Mechanisms and Pharmacologic Approaches. 259-284. DOI: 10.1016/B978-0-12-801577-3.00011-3  0.96
2014 Goldner JS, Quimby D, Richards MH, Zakaryan A, Miller S, Dickson D, Chilson J. Relations of Parenting to Adolescent Externalizing and Internalizing Distress Moderated by Perception of Neighborhood Danger. Journal of Clinical Child and Adolescent Psychology : the Official Journal For the Society of Clinical Child and Adolescent Psychology, American Psychological Association, Division 53. 1-14. PMID 25425100 DOI: 10.1080/15374416.2014.958838  0.72
2014 Robinson AP, Rodgers JM, Goings GE, Miller SD. Characterization of oligodendroglial populations in mouse demyelinating disease using flow cytometry: clues for MS pathogenesis. Plos One. 9: e107649. PMID 25247590 DOI: 10.1371/journal.pone.0107649  0.96
2014 Sarraj B, Ye J, Akl AI, Chen G, Wang JJ, Zhang Z, Abadja F, Abecassis M, Miller SD, Kansas GS, Ansari MJ. Impaired selectin-dependent leukocyte recruitment induces T-cell exhaustion and prevents chronic allograft vasculopathy and rejection. Proceedings of the National Academy of Sciences of the United States of America. 111: 12145-50. PMID 25092331 DOI: 10.1073/pnas.1303676111  0.96
2014 Yap WT, Song WK, Chauhan N, Scalise PN, Agarwal R, Miller SD, Shea LD. Quantification of particle-conjugated or particle-encapsulated peptides on interfering reagent backgrounds. Biotechniques. 57: 39-44. PMID 25005692 DOI: 10.2144/000114190  0.96
2014 Klaren RE, Motl RW, Woods JA, Miller SD. Effects of exercise in experimental autoimmune encephalomyelitis (an animal model of multiple sclerosis). Journal of Neuroimmunology. 274: 14-9. PMID 24999244 DOI: 10.1016/j.jneuroim.2014.06.014  0.96
2014 Blink SE, Caldis MW, Goings GE, Harp CT, Malissen B, Prinz I, Xu D, Miller SD. γδ T cell subsets play opposing roles in regulating experimental autoimmune encephalomyelitis. Cellular Immunology. 290: 39-51. PMID 24860937 DOI: 10.1016/j.cellimm.2014.04.013  0.96
2014 Flechner SM, Mulgoankar S, Melton LB, Waid TH, Agarwal A, Miller SD, Fokta F, Getts MT, Frederick TJ, Herrman JJ, Puisis JP, O'Toole L, Sung R, Shihab F, Wiseman AC, et al. First-in-human study of the safety and efficacy of TOL101 induction to prevent kidney transplant rejection. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 14: 1346-55. PMID 24751150 DOI: 10.1111/ajt.12698  0.96
2014 Terry RL, Miller SD. Molecular control of monocyte development. Cellular Immunology. 291: 16-21. PMID 24709055 DOI: 10.1016/j.cellimm.2014.02.008  0.96
2014 McCarthy DP, Hunter ZN, Chackerian B, Shea LD, Miller SD. Targeted immunomodulation using antigen-conjugated nanoparticles. Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology. 6: 298-315. PMID 24616452 DOI: 10.1002/wnan.1263  0.96
2014 Hunter Z, McCarthy DP, Yap WT, Harp CT, Getts DR, Shea LD, Miller SD. A biodegradable nanoparticle platform for the induction of antigen-specific immune tolerance for treatment of autoimmune disease. Acs Nano. 8: 2148-60. PMID 24559284 DOI: 10.1021/nn405033r  0.96
2014 Robinson AP, Harp CT, Noronha A, Miller SD. The experimental autoimmune encephalomyelitis (EAE) model of MS: utility for understanding disease pathophysiology and treatment. Handbook of Clinical Neurology. 122: 173-89. PMID 24507518 DOI: 10.1016/B978-0-444-52001-2.00008-X  0.96
2014 Banisadr G, Schwartz SR, Podojil JR, Piccinini LA, Lanker S, Miller SD, Miller RJ. Integrin/Chemokine receptor interactions in the pathogenesis of experimental autoimmune encephalomyelitis. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology. 9: 438-45. PMID 24477403 DOI: 10.1007/s11481-014-9521-9  0.96
2014 Getts DR, Terry RL, Getts MT, Deffrasnes C, Müller M, van Vreden C, Ashhurst TM, Chami B, McCarthy D, Wu H, Ma J, Martin A, Shae LD, Witting P, Kansas GS, ... ... Miller SD, et al. Therapeutic inflammatory monocyte modulation using immune-modifying microparticles. Science Translational Medicine. 6: 219ra7. PMID 24431111 DOI: 10.1126/scitranslmed.3007563  0.96
2013 Xu D, Miller SD, Koh S. Immune mechanisms in epileptogenesis. Frontiers in Cellular Neuroscience. 7: 195. PMID 24265605 DOI: 10.3389/fncel.2013.00195  0.96
2013 Getts DR, McCarthy DP, Miller SD. Exploiting apoptosis for therapeutic tolerance induction. Journal of Immunology (Baltimore, Md. : 1950). 191: 5341-6. PMID 24244028 DOI: 10.4049/jimmunol.1302070  0.96
2013 Eaton VL, Vasquez KO, Goings GE, Hunter ZN, Peterson JD, Miller SD. Optical tomographic imaging of near infrared imaging agents quantifies disease severity and immunomodulation of experimental autoimmune encephalomyelitis in vivo. Journal of Neuroinflammation. 10: 138. PMID 24237884 DOI: 10.1186/1742-2094-10-138  0.96
2013 Smarr CB, Bryce PJ, Miller SD. Antigen-specific tolerance in immunotherapy of Th2-associated allergic diseases. Critical Reviews in Immunology. 33: 389-414. PMID 24099300 DOI: 10.1615/CritRevImmunol.2013007046  0.96
2013 Mayes DA, Rizvi TA, Titus-Mitchell H, Oberst R, Ciraolo GM, Vorhees CV, Robinson AP, Miller SD, Cancelas JA, Stemmer-Rachamimov AO, Ratner N. Nf1 loss and Ras hyperactivation in oligodendrocytes induce NOS-driven defects in myelin and vasculature. Cell Reports. 4: 1197-212. PMID 24035394 DOI: 10.1016/j.celrep.2013.08.011  0.96
2013 Getts DR, Chastain EM, Terry RL, Miller SD. Virus infection, antiviral immunity, and autoimmunity. Immunological Reviews. 255: 197-209. PMID 23947356 DOI: 10.1111/imr.12091  0.96
2013 Rodgers JM, Robinson AP, Miller SD. Strategies for protecting oligodendrocytes and enhancing remyelination in multiple sclerosis. Discovery Medicine. 16: 53-63. PMID 23911232  0.96
2013 Wang S, Tasch J, Kheradmand T, Ulaszek J, Ely S, Zhang X, Hering BJ, Miller SD, Luo X. Transient B-cell depletion combined with apoptotic donor splenocytes induces xeno-specific T- and B-cell tolerance to islet xenografts. Diabetes. 62: 3143-50. PMID 23852699 DOI: 10.2337/db12-1678  0.96
2013 Wan E, Yeap XY, Dehn S, Terry R, Novak M, Zhang S, Iwata S, Han X, Homma S, Drosatos K, Lomasney J, Engman DM, Miller SD, Vaughan DE, Morrow JP, et al. Enhanced efferocytosis of apoptotic cardiomyocytes through myeloid-epithelial-reproductive tyrosine kinase links acute inflammation resolution to cardiac repair after infarction. Circulation Research. 113: 1004-12. PMID 23836795 DOI: 10.1161/CIRCRESAHA.113.301198  0.96
2013 Lutterotti A, Yousef S, Sputtek A, Stürner KH, Stellmann JP, Breiden P, Reinhardt S, Schulze C, Bester M, Heesen C, Schippling S, Miller SD, Sospedra M, Martin R. Antigen-specific tolerance by autologous myelin peptide-coupled cells: a phase 1 trial in multiple sclerosis. Science Translational Medicine. 5: 188ra75. PMID 23740901 DOI: 10.1126/scitranslmed.3006168  0.96
2013 Podojil JR, Liu LN, Marshall SA, Chiang MY, Goings GE, Chen L, Langermann S, Miller SD. B7-H4Ig inhibits mouse and human T-cell function and treats EAE via IL-10/Treg-dependent mechanisms. Journal of Autoimmunity. 44: 71-81. PMID 23683881 DOI: 10.1016/j.jaut.2013.04.001  0.96
2013 Robinson AP, Caldis MW, Harp CT, Goings GE, Miller SD. High-mobility group box 1 protein (HMGB1) neutralization ameliorates experimental autoimmune encephalomyelitis. Journal of Autoimmunity. 43: 32-43. PMID 23514872 DOI: 10.1016/j.jaut.2013.02.005  0.96
2013 Podojil JR, Miller SD. Targeting the B7 family of co-stimulatory molecules: successes and challenges. Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy. 27: 1-13. PMID 23329394 DOI: 10.1007/s40259-012-0001-6  0.96
2013 Getts DR, Getts MT, King NJC, Miller SD. Infectious Triggers of T Cell Autoimmunity The Autoimmune Diseases: Fifth Edition. 263-274. DOI: 10.1016/B978-0-12-384929-8.00019-8  0.96
2012 Prasad S, Xu D, Miller SD. Tolerance strategies employing antigen-coupled apoptotic cells and carboxylated PLG nanoparticles for the treatment of type 1 diabetes. The Review of Diabetic Studies : Rds. 9: 319-27. PMID 23804269 DOI: 10.1900/RDS.2012.9.319  0.96
2012 Rodgers JM, Miller SD. Cytokine control of inflammation and repair in the pathology of multiple sclerosis. The Yale Journal of Biology and Medicine. 85: 447-68. PMID 23239947  0.96
2012 Getts DR, Martin AJ, McCarthy DP, Terry RL, Hunter ZN, Yap WT, Getts MT, Pleiss M, Luo X, King NJ, Shea LD, Miller SD. Microparticles bearing encephalitogenic peptides induce T-cell tolerance and ameliorate experimental autoimmune encephalomyelitis. Nature Biotechnology. 30: 1217-24. PMID 23159881 DOI: 10.1038/nbt.2434  0.96
2012 Ren Z, Wang Y, Duan T, Patel J, Liggett T, Loda E, Brahma S, Goswami R, Grouse C, Byrne R, Stefoski D, Javed A, Miller SD, Balabanov R. Cross-immunoreactivity between bacterial aquaporin-Z and human aquaporin-4: potential relevance to neuromyelitis optica. Journal of Immunology (Baltimore, Md. : 1950). 189: 4602-11. PMID 23008451 DOI: 10.4049/jimmunol.1200486  0.96
2012 McCarthy DP, Richards MH, Miller SD. Mouse models of multiple sclerosis: experimental autoimmune encephalomyelitis and Theiler's virus-induced demyelinating disease. Methods in Molecular Biology (Clifton, N.J.). 900: 381-401. PMID 22933080 DOI: 10.1007/978-1-60761-720-4_19  0.96
2012 Kheradmand T, Wang S, Bryant J, Tasch JJ, Lerret N, Pothoven KL, Houlihan JL, Miller SD, Zhang ZJ, Luo X. Ethylenecarbodiimide-fixed donor splenocyte infusions differentially target direct and indirect pathways of allorecognition for induction of transplant tolerance. Journal of Immunology (Baltimore, Md. : 1950). 189: 804-12. PMID 22696445 DOI: 10.4049/jimmunol.1103705  0.96
2012 Prasad S, Kohm AP, McMahon JS, Luo X, Miller SD. Pathogenesis of NOD diabetes is initiated by reactivity to the insulin B chain 9-23 epitope and involves functional epitope spreading. Journal of Autoimmunity. 39: 347-53. PMID 22647732 DOI: 10.1016/j.jaut.2012.04.005  0.96
2012 Chang RA, Miller SD, Longnecker R. Epstein-Barr virus latent membrane protein 2A exacerbates experimental autoimmune encephalomyelitis and enhances antigen presentation function. Scientific Reports. 2: 353. PMID 22616025 DOI: 10.1038/srep00353  0.96
2012 Chastain EM, Miller SD. Molecular mimicry as an inducing trigger for CNS autoimmune demyelinating disease. Immunological Reviews. 245: 227-38. PMID 22168423 DOI: 10.1111/j.1600-065X.2011.01076.x  0.96
2012 Eagar TN, Miller SD. Helper T-cell subsets and control of the inflammatory response Clinical Immunology: Principles and Practice: Fourth Edition. 203-214. DOI: 10.1016/B978-0-7234-3691-1.00014-3  0.96
2011 Fu Y, Frederick TJ, Huff TB, Goings GE, Miller SD, Cheng JX. Paranodal myelin retraction in relapsing experimental autoimmune encephalomyelitis visualized by coherent anti-Stokes Raman scattering microscopy. Journal of Biomedical Optics. 16: 106006. PMID 22029353 DOI: 10.1117/1.3638180  0.96
2011 Smarr CB, Hsu CL, Byrne AJ, Miller SD, Bryce PJ. Antigen-fixed leukocytes tolerize Th2 responses in mouse models of allergy. Journal of Immunology (Baltimore, Md. : 1950). 187: 5090-8. PMID 21976774 DOI: 10.4049/jimmunol.1100608  0.96
2011 Getts DR, Turley DM, Smith CE, Harp CT, McCarthy D, Feeney EM, Getts MT, Martin AJ, Luo X, Terry RL, King NJ, Miller SD. Tolerance induced by apoptotic antigen-coupled leukocytes is induced by PD-L1+ and IL-10-producing splenic macrophages and maintained by T regulatory cells. Journal of Immunology (Baltimore, Md. : 1950). 187: 2405-17. PMID 21821796 DOI: 10.4049/jimmunol.1004175  0.96
2011 Getts DR, Shankar S, Chastain EM, Martin A, Getts MT, Wood K, Miller SD. Current landscape for T-cell targeting in autoimmunity and transplantation. Immunotherapy. 3: 853-70. PMID 21751954 DOI: 10.2217/imt.11.61  0.96
2011 Adipue IA, Wilcox JT, King C, Rice CA, Shaum KM, Suard CM, Brink Et, Miller SD, McMahon EJ. Characterization of a novel and spontaneous mouse model of inflammatory arthritis. Arthritis Research & Therapy. 13: R114. PMID 21749708 DOI: 10.1186/ar3399  0.96
2011 Podojil JR, Padval MV, Miller SD. Combination treatment of mice with CRx-153 (nortriptyline and desloratadine) decreases the severity of experimental autoimmune encephalomyelitis. Cellular Immunology. 270: 237-50. PMID 21696712 DOI: 10.1016/j.cellimm.2011.05.015  0.96
2011 Banisadr G, Frederick TJ, Freitag C, Ren D, Jung H, Miller SD, Miller RJ. The role of CXCR4 signaling in the migration of transplanted oligodendrocyte progenitors into the cerebral white matter. Neurobiology of Disease. 44: 19-27. PMID 21684336 DOI: 10.1016/j.nbd.2011.05.019  0.96
2011 Duncan DS, Miller SD. CNS expression of B7-H1 regulates pro-inflammatory cytokine production and alters severity of Theiler's virus-induced demyelinating disease. Plos One. 6: e18548. PMID 21494618 DOI: 10.1371/journal.pone.0018548  0.96
2011 Kheradmand T, Wang S, Gibly RF, Zhang X, Holland S, Tasch J, Graham JG, Kaufman DB, Miller SD, Shea LD, Luo X. Permanent protection of PLG scaffold transplanted allogeneic islet grafts in diabetic mice treated with ECDI-fixed donor splenocyte infusions. Biomaterials. 32: 4517-24. PMID 21458857 DOI: 10.1016/j.biomaterials.2011.03.009  0.96
2011 Ekong UD, Luo X, Yu M, Wang D, Miller SD, O'Gorman MR. Lymphocyte activation markers may predict the presence of donor specific alloreactivity in pediatric living related liver transplant recipients. Human Immunology. 72: 392-7. PMID 21315129 DOI: 10.1016/j.humimm.2011.02.003  0.96
2011 Richards MH, Getts MT, Podojil JR, Jin YH, Kim BS, Miller SD. Virus expanded regulatory T cells control disease severity in the Theiler's virus mouse model of MS. Journal of Autoimmunity. 36: 142-54. PMID 21273044 DOI: 10.1016/j.jaut.2010.12.005  0.96
2011 Dogan RN, Long N, Forde E, Dennis K, Kohm AP, Miller SD, Karpus WJ. CCL22 regulates experimental autoimmune encephalomyelitis by controlling inflammatory macrophage accumulation and effector function. Journal of Leukocyte Biology. 89: 93-104. PMID 20940325 DOI: 10.1189/jlb.0810442  0.96
2011 Chastain EM, Duncan DS, Rodgers JM, Miller SD. The role of antigen presenting cells in multiple sclerosis. Biochimica Et Biophysica Acta. 1812: 265-74. PMID 20637861 DOI: 10.1016/j.bbadis.2010.07.008  0.96
2010 Getts DR, Getts MT, McCarthy DP, Chastain EM, Miller SD. Have we overestimated the benefit of human(ized) antibodies? Mabs. 2: 682-94. PMID 20935511 DOI: 10.4161/mabs.2.6.13601  0.96
2010 Traka M, Arasi K, Avila RL, Podojil JR, Christakos A, Miller SD, Soliven B, Popko B. A genetic mouse model of adult-onset, pervasive central nervous system demyelination with robust remyelination. Brain : a Journal of Neurology. 133: 3017-29. PMID 20851998 DOI: 10.1093/brain/awq247  0.96
2010 Martin AJ, McCarthy D, Waltenbaugh C, Goings G, Luo X, Miller SD. Ethylenecarbodiimide-treated splenocytes carrying male CD4 epitopes confer histocompatibility Y chromosome antigen transplant protection by inhibiting CD154 upregulation. Journal of Immunology (Baltimore, Md. : 1950). 185: 3326-36. PMID 20713889 DOI: 10.4049/jimmunol.1000802  0.96
2010 Pothoven KL, Kheradmand T, Yang Q, Houlihan JL, Zhang H, Degutes M, Miller SD, Luo X. Rapamycin-conditioned donor dendritic cells differentiate CD4CD25Foxp3 T cells in vitro with TGF-beta1 for islet transplantation. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 10: 1774-84. PMID 20626386 DOI: 10.1111/j.1600-6143.2010.03199.x  0.96
2010 Gris D, Ye Z, Iocca HA, Wen H, Craven RR, Gris P, Huang M, Schneider M, Miller SD, Ting JP. NLRP3 plays a critical role in the development of experimental autoimmune encephalomyelitis by mediating Th1 and Th17 responses. Journal of Immunology (Baltimore, Md. : 1950). 185: 974-81. PMID 20574004 DOI: 10.4049/jimmunol.0904145  0.96
2010 Jin YH, Hou W, Kim SJ, Fuller AC, Kang B, Goings G, Miller SD, Kim BS. Type I interferon signals control Theiler's virus infection site, cellular infiltration and T cell stimulation in the CNS. Journal of Neuroimmunology. 226: 27-37. PMID 20538350 DOI: 10.1016/j.jneuroim.2010.05.028  0.96
2010 Zhang H, Podojil JR, Chang J, Luo X, Miller SD. TGF-beta-induced myelin peptide-specific regulatory T cells mediate antigen-specific suppression of induction of experimental autoimmune encephalomyelitis. Journal of Immunology (Baltimore, Md. : 1950). 184: 6629-36. PMID 20483764 DOI: 10.4049/jimmunol.0904044  0.96
2010 Getts MT, Miller SD. 99th Dahlem conference on infection, inflammation and chronic inflammatory disorders: triggering of autoimmune diseases by infections. Clinical and Experimental Immunology. 160: 15-21. PMID 20415846 DOI: 10.1111/j.1365-2249.2010.04132.x  0.96
2010 Luo X, Herold KC, Miller SD. Immunotherapy of type 1 diabetes: where are we and where should we be going? Immunity. 32: 488-99. PMID 20412759 DOI: 10.1016/j.immuni.2010.04.002  0.96
2010 Getts MT, Richards MH, Miller SD. A critical role for virus-specific CD8(+) CTLs in protection from Theiler's virus-induced demyelination in disease-susceptible SJL mice. Virology. 402: 102-11. PMID 20381109 DOI: 10.1016/j.virol.2010.02.031  0.96
2010 Rodgers JM, Zhou L, Miller SD. Act1, scene brain: astrocytes play a lead role. Immunity. 32: 302-4. PMID 20346771 DOI: 10.1016/j.immuni.2010.03.009  0.96
2010 Miller SD, Karpus WJ, Davidson TS. Experimental autoimmune encephalomyelitis in the mouse. Current Protocols in Immunology / Edited by John E. Coligan ... [Et Al.]. Unit 15.1. PMID 20143314 DOI: 10.1002/0471142735.im1501s19  0.96
2010 Turley DM, Miller SD. Prospects for antigen-specific tolerance based therapies for the treatment of multiple sclerosis. Results and Problems in Cell Differentiation. 51: 217-35. PMID 19130025 DOI: 10.1007/400_2008_13  0.96
2009 Martin AJ, Zhou L, Miller SD. MicroRNA--managing the TH-17 inflammatory response. Nature Immunology. 10: 1229-31. PMID 19915620 DOI: 10.1038/ni1209-1229  0.96
2009 Podojil JR, Miller SD. Molecular mechanisms of T-cell receptor and costimulatory molecule ligation/blockade in autoimmune disease therapy. Immunological Reviews. 229: 337-55. PMID 19426232 DOI: 10.1111/j.1600-065X.2009.00773.x  0.96
2009 Olson JK, Miller SD. The innate immune response affects the development of the autoimmune response in Theiler's virus-induced demyelinating disease. Journal of Immunology (Baltimore, Md. : 1950). 182: 5712-22. PMID 19380818 DOI: 10.4049/jimmunol.0801940  0.96
2009 Münz C, Lünemann JD, Getts MT, Miller SD. Antiviral immune responses: triggers of or triggered by autoimmunity? Nature Reviews. Immunology. 9: 246-58. PMID 19319143 DOI: 10.1038/nri2527  0.96
2009 Blink SE, Miller SD. The contribution of gammadelta T cells to the pathogenesis of EAE and MS. Current Molecular Medicine. 9: 15-22. PMID 19199938 DOI: 10.2174/156652409787314516  0.96
2009 Bai L, Lennon DP, Eaton V, Maier K, Caplan AI, Miller SD, Miller RH. Human bone marrow-derived mesenchymal stem cells induce Th2-polarized immune response and promote endogenous repair in animal models of multiple sclerosis. Glia. 57: 1192-203. PMID 19191336 DOI: 10.1002/glia.20841  0.96
2009 Podojil JR, Miller SD. Cross-linking of CD80 on CD4+ T cells activates a calcium-dependent signaling pathway. Journal of Immunology (Baltimore, Md. : 1950). 182: 766-73. PMID 19124719  0.96
2009 Ercolini AM, Miller SD. The role of infections in autoimmune disease Clinical and Experimental Immunology. 155: 1-15. PMID 19076824 DOI: 10.1111/j.1365-2249.2008.03834.x  0.96
2009 Ekong UD, Miller SD, O'Gorman MR. In vitro assays of allosensitization. Pediatric Transplantation. 13: 25-34. PMID 19017286 DOI: 10.1111/j.1399-3046.2008.01042.x  0.96
2008 Getts MT, Getts DR, Kohm AP, Miller SD. Endoplasmic reticulum stress response as a potential therapeutic target in multiple sclerosis. Therapy (London, England : 2004). 5: 631-640. PMID 20357912 DOI: 10.2217/14750708.5.5.631  0.96
2008 Podojil JR, Turley DM, Miller SD. Therapeutic blockade of T-cell antigen receptor signal transduction and costimulation in autoimmune disease. Advances in Experimental Medicine and Biology. 640: 234-51. PMID 19065796 DOI: 10.1007/978-0-387-09789-3_18  0.96
2008 Greene MT, Ercolini AM, DeGutes M, Miller SD. Differential induction of experimental autoimmune encephalomyelitis by myelin basic protein molecular mimics in mice humanized for HLA-DR2 and an MBP(85-99)-specific T cell receptor. Journal of Autoimmunity. 31: 399-407. PMID 19008075 DOI: 10.1016/j.jaut.2008.09.004  0.96
2008 Edlynn ES, Gaylord-Harden NK, Richards MH, Miller SA. African American inner-city youth exposed to violence: coping skills as a moderator for anxiety. The American Journal of Orthopsychiatry. 78: 249-58. PMID 18954188 DOI: 10.1037/a0013948  0.56
2008 Goings GE, Greisman A, James RE, Abram LK, Begolka WS, Miller SD, Szele FG. Hematopoietic cell activation in the subventricular zone after Theiler's virus infection. Journal of Neuroinflammation. 5: 44. PMID 18922161 DOI: 10.1186/1742-2094-5-44  0.96
2008 Schreiner B, Bailey SL, Shin T, Chen L, Miller SD. PD-1 ligands expressed on myeloid-derived APC in the CNS regulate T-cell responses in EAE. European Journal of Immunology. 38: 2706-17. PMID 18825752 DOI: 10.1002/eji.200838137  0.96
2008 Zhang H, Podojil JR, Luo X, Miller SD. Intrinsic and induced regulation of the age-associated onset of spontaneous experimental autoimmune encephalomyelitis. Journal of Immunology (Baltimore, Md. : 1950). 181: 4638-47. PMID 18802066  0.96
2008 Luo X, Pothoven KL, McCarthy D, DeGutes M, Martin A, Getts DR, Xia G, He J, Zhang X, Kaufman DB, Miller SD. ECDI-fixed allogeneic splenocytes induce donor-specific tolerance for long-term survival of islet transplants via two distinct mechanisms. Proceedings of the National Academy of Sciences of the United States of America. 105: 14527-32. PMID 18796615 DOI: 10.1073/pnas.0805204105  0.96
2008 Nair A, Frederick TJ, Miller SD. Astrocytes in multiple sclerosis: A product of their environment Cellular and Molecular Life Sciences. 65: 2702-2720. PMID 18516496 DOI: 10.1007/s00018-008-8059-5  0.96
2008 Cannon JL, Collins A, Mody PD, Balachandran D, Henriksen KJ, Smith CE, Tong J, Clay BS, Miller SD, Sperling AI. CD43 regulates Th2 differentiation and inflammation. Journal of Immunology (Baltimore, Md. : 1950). 180: 7385-93. PMID 18490738  0.96
2008 Bailey-Bucktrout SL, Caulkins SC, Goings G, Fischer JA, Dzionek A, Miller SD. Cutting edge: central nervous system plasmacytoid dendritic cells regulate the severity of relapsing experimental autoimmune encephalomyelitis. Journal of Immunology (Baltimore, Md. : 1950). 180: 6457-61. PMID 18453561  0.96
2008 Carpentier PA, Getts MT, Miller SD. Pro-inflammatory functions of astrocytes correlate with viral clearance and strain-dependent protection from TMEV-induced demyelinating disease. Virology. 375: 24-36. PMID 18289626 DOI: 10.1016/j.virol.2008.01.024  0.96
2008 Carpentier PA, Duncan DS, Miller SD. Glial toll-like receptor signaling in central nervous system infection and autoimmunity. Brain, Behavior, and Immunity. 22: 140-7. PMID 17920811 DOI: 10.1016/j.bbi.2007.08.011  0.96
2008 Carpentier PA, Duncan DS, Miller SD. Pattern recognition receptors in CNS disease Central Nervous System Diseases and Inflammation. 131-152. DOI: 10.1007/978-0-387-73894-9_7  0.96
2008 Bailey SL, Miller SD. CNS dendritic cells in inflammation and disease Central Nervous System Diseases and Inflammation. 263-275. DOI: 10.1007/978-0-387-73894-9_13  0.96
2007 Miller SD, Karpus WJ. Experimental autoimmune encephalomyelitis in the mouse. Current Protocols in Immunology / Edited by John E. Coligan ... [Et Al.]. Unit 15.1. PMID 18432984 DOI: 10.1002/0471142735.im1501s77  0.96
2007 Miller SD, Turley DM, Podojil JR. Antigen-specific tolerance strategies for the prevention and treatment of autoimmune disease. Nature Reviews. Immunology. 7: 665-77. PMID 17690713 DOI: 10.1038/nri2153  0.96
2007 Frederick TJ, Miller SD. Arresting autoimmunity by blocking beta-arrestin 1. Nature Immunology. 8: 791-2. PMID 17641656 DOI: 10.1038/ni0807-791  0.96
2007 Getts MT, Kim BS, Miller SD. Differential outcome of tolerance induction in naive versus activated Theiler's virus epitope-specific CD8+ cytotoxic T cells. Journal of Virology. 81: 6584-93. PMID 17428853 DOI: 10.1128/JVI.00008-07  0.96
2007 Bennett JL, Elhofy A, Charo I, Miller SD, Dal Canto MC, Karpus WJ. CCR2 regulates development of Theiler's murine encephalomyelitis virus-induced demyelinating disease. Viral Immunology. 20: 19-33. PMID 17425418 DOI: 10.1089/vim.2006.0068  0.96
2007 Miller SD, McMahon EJ, Schreiner B, Bailey SL. Antigen presentation in the CNS by myeloid dendritic cells drives progression of relapsing experimental autoimmune encephalomyelitis. Annals of the New York Academy of Sciences. 1103: 179-91. PMID 17376826 DOI: 10.1196/annals.1394.023  0.96
2007 Ercolini AM, Ludovic Croxford J, Degutes M, Miller SD. Cross-reactivity between peptide mimics of the immunodominant myelin proteolipid protein epitope PLP139-151: comparison of peptide priming in CFA vs. viral delivery. Journal of Neuroimmunology. 186: 5-18. PMID 17376542 DOI: 10.1016/j.jneuroim.2007.02.002  0.96
2007 Turley DM, Miller SD. Peripheral tolerance induction using ethylenecarbodiimide-fixed APCs uses both direct and indirect mechanisms of antigen presentation for prevention of experimental autoimmune encephalomyelitis. Journal of Immunology (Baltimore, Md. : 1950). 178: 2212-20. PMID 17277126  0.96
2007 Lin W, Bailey SL, Ho H, Harding HP, Ron D, Miller SD, Popko B. The integrated stress response prevents demyelination by protecting oligodendrocytes against immune-mediated damage. The Journal of Clinical Investigation. 117: 448-56. PMID 17273557 DOI: 10.1172/JCI29571  0.96
2007 Carpentier PA, Williams BR, Miller SD. Distinct roles of protein kinase R and toll-like receptor 3 in the activation of astrocytes by viral stimuli. Glia. 55: 239-52. PMID 17091495 DOI: 10.1002/glia.20450  0.96
2007 Schreiner B, Bailey SL, Miller SD. T-cell response dynamics in animal models of multiple sclerosis: Implications for immunotherapies Expert Review of Clinical Immunology. 3: 57-72. DOI: 10.1586/1744666X.3.1.57  0.96
2006 Smith CE, Miller SD. Multi-peptide coupled-cell tolerance ameliorates ongoing relapsing EAE associated with multiple pathogenic autoreactivities. Journal of Autoimmunity. 27: 218-31. PMID 17289470 DOI: 10.1016/j.jaut.2006.12.002  0.96
2006 Croxford JL, Ercolini AM, Degutes M, Miller SD. Structural requirements for initiation of cross-reactivity and CNS autoimmunity with a PLP139-151 mimic peptide derived from murine hepatitis virus. European Journal of Immunology. 36: 2671-80. PMID 16981179 DOI: 10.1002/eji.200635876  0.96
2006 McMahon EJ, Bailey SL, Miller SD. CNS dendritic cells: Critical participants in CNS inflammation? Neurochemistry International. 49: 195-203. PMID 16730862 DOI: 10.1016/j.neuint.2006.04.004  0.96
2006 Bailey SL, Carpentier PA, McMahon EJ, Begolka WS, Miller SD. Innate and adaptive immune responses of the central nervous system. Critical Reviews in Immunology. 26: 149-88. PMID 16700651 DOI: 10.1207/s15326977ea1103&4_2  0.96
2006 Plant SR, Wang Y, Vasseur S, Thrash JC, McMahon EJ, Bergstralh DT, Arnett HA, Miller SD, Carson MJ, Iovanna JL, Ting JP. Upregulation of the stress-associated gene p8 in mouse models of demyelination and in multiple sclerosis tissues. Glia. 53: 529-37. PMID 16374777 DOI: 10.1002/glia.20297  0.96
2005 Kohm AP, Turley DM, Miller SD. Targeting the TCR: T-cell receptor and peptide-specific tolerance-based strategies for restoring self-tolerance in CNS autoimmune disease. International Reviews of Immunology. 24: 361-92. PMID 16318987 DOI: 10.1080/08830180500371207  0.96
2005 Croxford JL, Wang K, Miller SD, Engman DM, Tyler KM. Effects of cannabinoid treatment on Chagas disease pathogenesis: balancing inhibition of parasite invasion and immunosuppression. Cellular Microbiology. 7: 1592-602. PMID 16207246 DOI: 10.1111/j.1462-5822.2005.00577.x  0.96
2005 Ercolini AM, Miller SD. Role of immunologic cross-reactivity in neurological diseases. Neurological Research. 27: 726-33. PMID 16197809 DOI: 10.1179/016164105X49508  0.96
2005 Minter LM, Turley DM, Das P, Shin HM, Joshi I, Lawlor RG, Cho OH, Palaga T, Gottipati S, Telfer JC, Kostura L, Fauq AH, Simpson K, Such KA, Miele L, ... ... Miller SD, et al. Inhibitors of gamma-secretase block in vivo and in vitro T helper type 1 polarization by preventing Notch upregulation of Tbx21. Nature Immunology. 6: 680-8. PMID 15991363 DOI: 10.1038/ni1209x  0.96
2005 Smith CE, Eagar TN, Strominger JL, Miller SD. Differential induction of IgE-mediated anaphylaxis after soluble vs. cell-bound tolerogenic peptide therapy of autoimmune encephalomyelitis. Proceedings of the National Academy of Sciences of the United States of America. 102: 9595-600. PMID 15983366 DOI: 10.1073/pnas.0504131102  0.96
2005 Croxford JL, Olson JK, Anger HA, Miller SD. Initiation and exacerbation of autoimmune demyelination of the central nervous system via virus-induced molecular mimicry: implications for the pathogenesis of multiple sclerosis. Journal of Virology. 79: 8581-90. PMID 15956599 DOI: 10.1128/JVI.79.13.8581-8590.2005  0.96
2005 Carpentier PA, Begolka WS, Olson JK, Elhofy A, Karpus WJ, Miller SD. Differential activation of astrocytes by innate and adaptive immune stimuli. Glia. 49: 360-74. PMID 15538753 DOI: 10.1002/glia.20117  0.96
2005 Olson JK, Miller SD. The role of T cells and the innate immune system in the pathogenesis of theiler's virus demyeliating disease Experimental Models of Multiple Sclerosis. 645-657. DOI: 10.1007/0-387-25518-4_32  0.96
2005 Melvold RW, Miller SD. Immunogenetics, resistance, and susceptibility to theiler's virus infection Experimental Models of Multiple Sclerosis. 629-644. DOI: 10.1007/0-387-25518-4_31  0.96
2004 Howard LM, Miller SD. Immunotherapy targeting the CD40/CD154 costimulatory pathway for treatment of autoimmune disease Autoimmunity. 37: 411-418. PMID 15621565 DOI: 10.1080/08916930410001716095  0.96
2004 Olson JK, Miller SD. Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs. Journal of Immunology (Baltimore, Md. : 1950). 173: 3916-24. PMID 15356140 DOI: 10.4049/jimmunol.173.6.3916  0.96
2004 Fuller KG, Olson JK, Howard LM, Croxford JL, Miller SD. Mouse models of multiple sclerosis: experimental autoimmune encephalomyelitis and Theiler's virus-induced demyelinating disease. Methods in Molecular Medicine. 102: 339-61. PMID 15286394 DOI: 10.1385/1-59259-805-6:339  0.96
2004 Eagar TN, Turley DM, Padilla J, Karandikar NJ, Tan L, Bluestone JA, Miller SD. CTLA-4 regulates expansion and differentiation of Th1 cells following induction of peripheral T cell tolerance. Journal of Immunology (Baltimore, Md. : 1950). 172: 7442-50. PMID 15187122  0.96
2004 Mack CL, Tucker RM, Sokol RJ, Karrer FM, Kotzin BL, Whitington PF, Miller SD. Biliary atresia is associated with CD4+ Th1 cell-mediated portal tract inflammation. Pediatric Research. 56: 79-87. PMID 15128911 DOI: 10.1203/01.PDR.0000130480.51066.FB  0.96
2004 Olson JK, Ludovic Croxford J, Miller SD. Innate and adaptive immune requirements for induction of autoimmune demyelinating disease by molecular mimicry. Molecular Immunology. 40: 1103-8. PMID 15036915 DOI: 10.1016/j.molimm.2003.11.010  0.96
2003 Kohm AP, Carpentier PA, Miller SD. Regulation of experimental autoimmune encephalomyelitis (EAE) by CD4+CD25+ regulatory T cells. Novartis Foundation Symposium. 252: 45-52; discussion 52. PMID 14609211  0.96
2003 Mack CL, Vanderlugt-Castaneda CL, Neville KL, Miller SD. Microglia are activated to become competent antigen presenting and effector cells in the inflammatory environment of the Theiler's virus model of multiple sclerosis. Journal of Neuroimmunology. 144: 68-79. PMID 14597100 DOI: 10.1016/j.jneuroim.2003.08.032  0.96
2003 Olson JK, Zamvil SS, Miller SD. Efficient technique for immortalization of murine microglial cells relevant for studies in murine models of multiple sclerosis. Journal of Neuroscience Methods. 128: 33-43. PMID 12948546 DOI: 10.1016/S0165-0270(03)00145-6  0.96
2003 Theien BE, Vanderlugt CL, Nickerson-Nutter C, Cornebise M, Scott DM, Perper SJ, Whalley ET, Miller SD. Differential effects of treatment with a small-molecule VLA-4 antagonist before and after onset of relapsing EAE. Blood. 102: 4464-71. PMID 12933585 DOI: 10.1182/blood-2003-03-0974  0.72
2003 Howard LM, Neville KL, Haynes LM, Dal Canto MC, Miller SD. CD154 blockade results in transient reduction in Theiler's murine encephalomyelitis virus-induced demyelinating disease. Journal of Virology. 77: 2247-50. PMID 12525660 DOI: 10.1128/JVI.77.3.2247-2250.2003  0.96
2002 Croxford JL, Olson JK, Miller SD. Epitope spreading and molecular mimicry as triggers of autoimmunity in the Theiler's virus-induced demyelinating disease model of multiple sclerosis. Autoimmunity Reviews. 1: 251-60. PMID 12848977 DOI: 10.1016/S1568-9972(02)00080-0  0.96
2002 Kohm AP, Carpentier PA, Anger HA, Miller SD. Cutting edge: CD4+CD25+ regulatory T cells suppress antigen-specific autoreactive immune responses and central nervous system inflammation during active experimental autoimmune encephalomyelitis. Journal of Immunology (Baltimore, Md. : 1950). 169: 4712-6. PMID 12391178  0.96
2002 Olson JK, Eagar TN, Miller SD. Functional activation of myelin-specific T cells by virus-induced molecular mimicry. Journal of Immunology (Baltimore, Md. : 1950). 169: 2719-26. PMID 12193746  0.96
2002 Howard LM, Dal Canto MC, Miller SD. Transient anti-CD154-mediated immunotherapy of ongoing relapsing experimental autoimmune encephalomyelitis induces long-term inhibition of disease relapses. Journal of Neuroimmunology. 129: 58-65. PMID 12161021 DOI: 10.1016/S0165-5728(02)00175-3  0.96
2002 Girvin AM, Gordon KB, Welsh CJ, Clipstone NA, Miller SD. Differential abilities of central nervous system resident endothelial cells and astrocytes to serve as inducible antigen-presenting cells. Blood. 99: 3692-701. PMID 11986225 DOI: 10.1182/blood-2001-12-0229  0.96
2002 Tompkins SM, Miller SD. An array of possibilities for multiple sclerosis Nature Medicine. 8: 451-453. PMID 11984584 DOI: 10.1038/nm0502-451  0.96
2002 Eagar TN, Karandikar NJ, Bluestone JA, Miller SD. The role of CTLA-4 in induction and maintenance of peripheral T cell tolerance. European Journal of Immunology. 32: 972-81. PMID 11920563 DOI: 10.1002/1521-4141(200204)32:4<972::AID-IMMU972>3.0.CO;2-M  0.96
2002 Girvin AM, Dal Canto MC, Miller SD. CD40/CD40L interaction is essential for the induction of EAE in the absence of CD28-mediated co-stimulation. Journal of Autoimmunity. 18: 83-94. PMID 11908941 DOI: 10.1006/jaut.2001.0573  0.96
2002 Neville KL, Padilla J, Miller SD. Myelin-specific tolerance attenuates the progression of a virus-induced demyelinating disease: implications for the treatment of MS. Journal of Neuroimmunology. 123: 18-29. PMID 11880145 DOI: 10.1016/S0165-5728(01)00479-9  0.96
2002 Rasley A, Bost KL, Olson JK, Miller SD, Marriott I. Expression of functional NK-1 receptors in murine microglia. Glia. 37: 258-67. PMID 11857684 DOI: 10.1002/glia.10034  0.96
2002 Howard LM, Ostrovidov S, Smith CE, Dal Canto MC, Miller SD. Normal Th1 development following long-term therapeutic blockade of CD154-CD40 in experimental autoimmune encephalomyelitis. The Journal of Clinical Investigation. 109: 233-41. PMID 11805135 DOI: 10.1172/JCI14374  0.96
2001 Begolka WS, Haynes LM, Olson JK, Padilla J, Neville KL, Dal Canto M, Palma J, Kim BS, Miller SD. CD8-deficient SJL mice display enhanced susceptibility to Theiler's virus infection and increased demyelinating pathology. Journal of Neurovirology. 7: 409-20. PMID 11582513 DOI: 10.1080/135502801753170264  0.96
2001 Olson JK, Croxford JL, Miller SD. Virus-induced autoimmunity: potential role of viruses in initiation, perpetuation, and progression of T-cell-mediated autoimmune disease. Viral Immunology. 14: 227-50. PMID 11572634 DOI: 10.1089/088282401753266756  0.96
2001 Olson JK, Girvin AM, Miller SD. Direct activation of innate and antigen-presenting functions of microglia following infection with Theiler's virus. Journal of Virology. 75: 9780-9. PMID 11559811 DOI: 10.1128/JVI.75.20.9780-9789.2001  0.96
2001 Salomon B, Rhee L, Bour-Jordan H, Hsin H, Montag A, Soliven B, Arcella J, Girvin AM, Padilla J, Miller SD, Bluestone JA. Development of spontaneous autoimmune peripheral polyneuropathy in B7-2-deficient NOD mice. The Journal of Experimental Medicine. 194: 677-84. PMID 11535635 DOI: 10.1084/jem.194.5.677  0.96
2001 Miller SD, Eagar TN. Functional role of epitope spreading in the chronic pathogenesis of autoimmune and virus-induced demyelinating diseases. Advances in Experimental Medicine and Biology. 490: 99-107. PMID 11505979  0.96
2001 Olson JK, Croxford JL, Calenoff MA, Dal Canto MC, Miller SD. A virus-induced molecular mimicry model of multiple sclerosis. The Journal of Clinical Investigation. 108: 311-8. PMID 11457884 DOI: 10.1172/JCI13032  0.96
2001 Miller SD, Katz-Levy Y, Neville KL, Vanderlugt CL. Virus-induced autoimmunity: epitope spreading to myelin autoepitopes in Theiler's virus infection of the central nervous system. Advances in Virus Research. 56: 199-217. PMID 11450300  0.96
2001 Xu L, Robinson N, Miller SD, Chan LS. Characterization of BALB/c mice B lymphocyte autoimmune responses to skin basement membrane component type XVII collagen, the target antigen of autoimmune skin disease bullous pemphigoid Immunology Letters. 77: 105-111. PMID 11377704 DOI: 10.1016/S0165-2478(01)00212-7  0.96
2001 Theien BE, Vanderlugt CL, Eagar TN, Nickerson-Nutter C, Nazareno R, Kuchroo VK, Miller SD. Discordant effects of anti-VLA-4 treatment before and after onset of relapsing experimental autoimmune encephalomyelitis. The Journal of Clinical Investigation. 107: 995-1006. PMID 11306603 DOI: 10.1172/JCI11717  0.96
2001 Godsel LM, Wang K, Schodin BA, Leon JS, Miller SD, Engman DM. Prevention of autoimmune myocarditis through the induction of antigen-specific peripheral immune tolerance. Circulation. 103: 1709-14. PMID 11274001 DOI: 10.1161/01.CIR.103.12.1709  0.96
2000 Suvannavejh GC, Lee HO, Padilla J, Dal Canto MC, Barrett TA, Miller SD. Divergent roles for p55 and p75 tumor necrosis factor receptors in the pathogenesis of MOG(35-55)-induced experimental autoimmune encephalomyelitis. Cellular Immunology. 205: 24-33. PMID 11078604 DOI: 10.1006/cimm.2000.1706  0.96
2000 Katz-Levy Y, Neville KL, Padilla J, Rahbe S, Begolka WS, Girvin AM, Olson JK, Vanderlugt CL, Miller SD. Temporal development of autoreactive Th1 responses and endogenous presentation of self myelin epitopes by central nervous system-resident APCs in Theiler's virus-infected mice. Journal of Immunology (Baltimore, Md. : 1950). 165: 5304-14. PMID 11046065  0.96
2000 Sabelko-Downes KA, Gimenez MT, Suvannavejh GC, Miller SD, Russell JH. Genetic control of pathogenic mechanisms in autoimmune demyelinating disease. Journal of Neuroimmunology. 110: 168-76. PMID 11024547 DOI: 10.1016/S0165-5728(00)00350-7  0.96
2000 Karandikar NJ, Eagar TN, Vanderlugt CL, Bluestone JA, Miller SD. CTLA-4 downregulates epitope spreading and mediates remission in relapsing experimental autoimmune encephalomyelitis. Journal of Neuroimmunology. 109: 173-80. PMID 10996219 DOI: 10.1016/S0165-5728(00)00322-2  0.96
2000 Neville KL, Dal Canto MC, Bluestone JA, Miller SD. CD28 costimulatory blockade exacerbates disease severity and accelerates epitope spreading in a virus-induced autoimmune disease. Journal of Virology. 74: 8349-57. PMID 10954534 DOI: 10.1128/JVI.74.18.8349-8357.2000  0.96
2000 Haynes LM, Vanderlugt CL, Dal Canto MC, Melvold RW, Miller SD. CD8(+) T cells from Theiler's virus-resistant BALB/cByJ mice downregulate pathogenic virus-specific CD4(+) T cells. Journal of Neuroimmunology. 106: 43-52. PMID 10814781 DOI: 10.1016/S0165-5728(00)00212-5  0.72
2000 Vanderlugt CL, Rahbe SM, Elliott PJ, Dal Canto MC, Miller SD. Treatment of established relapsing experimental autoimmune encephalomyelitis with the proteasome inhibitor PS-519. Journal of Autoimmunity. 14: 205-11. PMID 10756082 DOI: 10.1006/jaut.2000.0370  0.72
2000 Dal Canto MC, Calenoff MA, Miller SD, Vanderlugt CL. Lymphocytes from mice chronically infected with Theiler's murine encephalomyelitis virus produce demyelination of organotypic cultures after stimulation with the major encephalitogenic epitope of myelin proteolipid protein. Epitope spreading in TMEV infection has functional activity. Journal of Neuroimmunology. 104: 79-84. PMID 10683517 DOI: 10.1016/S0165-5728(99)00230-1  0.72
2000 Suvannavejh GC, Dal Canto MC, Matis LA, Miller SD. Fas-mediated apoptosis in clinical remissions of relapsing experimental autoimmune encephalomyelitis. The Journal of Clinical Investigation. 105: 223-31. PMID 10642601 DOI: 10.1172/JCI8561  0.96
2000 Vanderlugt CL, Neville KL, Nikcevich KM, Eagar TN, Bluestone JA, Miller SD. Pathologic role and temporal appearance of newly emerging autoepitopes in relapsing experimental autoimmune encephalomyelitis. Journal of Immunology (Baltimore, Md. : 1950). 164: 670-8. PMID 10623809  0.96
2000 Girvin AM, Dal Canto MC, Rhee L, Salomon B, Sharpe A, Bluestone JA, Miller SD. A critical role for B7/CD28 costimulation in experimental autoimmune encephalomyelitis: a comparative study using costimulatory molecule-deficient mice and monoclonal antibody blockade. Journal of Immunology (Baltimore, Md. : 1950). 164: 136-43. PMID 10605004  0.96
1999 Huffman LM, Fife BT, Begolka WS, Miller SD, Karpus WJ. Central nervous system chemokine expression during Theiler's virus-induced demyelinating disease Journal of Neurovirology. 5: 635-642. PMID 10602404 DOI: 10.3109/13550289909021292  0.96
1999 Katz-Levy Y, Neville KL, Girvin AM, Vanderlugt CL, Pope JG, Tan LJ, Miller SD. Endogenous presentation of self myelin epitopes by CNS-resident APCs in Theiler's virus-infected mice. The Journal of Clinical Investigation. 104: 599-610. PMID 10487774 DOI: 10.1172/JCI7292  0.96
1999 Nicholson SM, Haynes LM, Vanderlugt CL, Miller SD, Melvold RW. The role of protective CD8+ T cells in resistance of BALB/c mice to Theiler's murine encephalomyelitis virus-induced demyelinating disease: regulatory vs. lytic. Journal of Neuroimmunology. 98: 136-46. PMID 10430047 DOI: 10.1016/S0165-5728(99)00090-9  0.72
1999 Howard LM, Miga AJ, Vanderlugt CL, Dal Canto MC, Laman JD, Noelle RJ, Miller SD. Mechanisms of immunotherapeutic intervention by anti-CD40L (CD154) antibody in an animal model of multiple sclerosis. The Journal of Clinical Investigation. 103: 281-90. PMID 9916140 DOI: 10.1172/JCI5388  0.96
1998 Smith Begolka W, Miller SD. Cytokines as intrinsic and exogenous regulators of pathogenesis in experimental autoimmune encephalomyelitis Research in Immunology. 149. PMID 9923632 DOI: 10.1016/S0923-2494(99)80004-2  0.96
1998 Miller SD, Shevach EM. Immunoregulation of experimental autoimmune encephalomyelitis: Editorial overview Research in Immunology. 149. PMID 9923630 DOI: 10.1016/S0923-2494(99)80002-9  0.96
1998 Vanderlugt CL, Begolka WS, Neville KL, Katz-Levy Y, Howard LM, Eagar TN, Bluestone JA, Miller SD. The functional significance of epitope spreading and its regulation by co-stimulatory molecules. Immunological Reviews. 164: 63-72. PMID 9795764 DOI: 10.1111/j.1600-065X.1998.tb01208.x  0.96
1998 Karandikar NJ, Vanderlugt CL, Bluestone JA, Miller SD. Targeting the B7/CD28:CTLA-4 costimulatory system in CNS autoimmune disease. Journal of Neuroimmunology. 89: 10-8. PMID 9726820 DOI: 10.1016/S0165-5728(98)00058-7  0.72
1998 Chan LS, Vanderlugt CJ, Hashimoto T, Nishikawa T, Zone JJ, Black MM, Wojnarowska F, Stevens SR, Chen M, Fairley JA, Woodley DT, Miller SD, Gordon KB. Epitope spreading: lessons from autoimmune skin diseases. The Journal of Investigative Dermatology. 110: 103-9. PMID 9457902 DOI: 10.1046/j.1523-1747.1998.00107.x  0.96
1997 Vanderlugt CL, Karandikar NJ, Lenschow DJ, Dal Canto MC, Bluestone JA, Miller SD. Treatment with intact anti-B7-1 mAb during disease remission enhances epitope spreading and exacerbates relapses in R-EAE. Journal of Neuroimmunology. 79: 113-8. PMID 9394783 DOI: 10.1016/S0165-5728(97)00108-2  0.72
1997 Miller SD, Vanderlugt CL, Begolka WS, Pao W, Yauch RL, Neville KL, Katz-Levy Y, Carrizosa A, Kim BS. Persistent infection with Theiler's virus leads to CNS autoimmunity via epitope spreading. Nature Medicine. 3: 1133-6. PMID 9334726 DOI: 10.1038/nm1097-1133  0.96
1997 Miller SD, Vanderlugt CL, Begolka WS, Pao W, Neville KL, Yauch RL, Kim BS. Epitope spreading leads to myelin-specific autoimmune responses in SJL mice chronically infected with Theiler's virus. Journal of Neurovirology. 3: S62-5. PMID 9179798  0.96
1997 McRae BL, Karandikar NJ, Miller SD. Degenerate antigen recognition by CD4+ effector T cells in experimental autoimmune encephalomyelitis. Journal of Neuroimmunology. 75: 156-62. PMID 9143249 DOI: 10.1016/S0165-5728(97)00014-3  0.32
1996 Vandenbark AA, Vainiene M, Ariail K, Miller SD, Offner H. Prevention and treatment of relapsing autoimmune encephalomyelitis with myelin peptide-coupled splenocytes Journal of Neuroscience Research. 45: 430-438. PMID 8872903 DOI: 10.1002/(SICI)1097-4547(19960815)45:4<430::AID-JNR12>3.0.CO;2-4  0.96
1996 Karandikar NJ, Vanderlugt CL, Walunas TL, Miller SD, Bluestone JA. CTLA-4: a negative regulator of autoimmune disease. The Journal of Experimental Medicine. 184: 783-8. PMID 8760834 DOI: 10.1084/jem.184.2.783  0.72
1995 Lipton HL, Melvold R, Miller SD, Dal Canto MC. Mutation of a major histocompatibility class I locus, H-2D, leads to an increased virus burden and disease susceptibility in Theiler's virus-induced demyelinating disease. Journal of Neurovirology. 1: 138-44. PMID 9222352 DOI: 10.3109/13550289509113960  0.4
1995 McRae BL, Nikcevich KM, Karpus WJ, Hurst SD, Miller SD. Differential recognition of peptide analogs by naive verses activated PLP 139-151-specific CD4+ T cells. Journal of Neuroimmunology. 60: 17-28. PMID 7543908 DOI: 10.1016/0165-5728(95)00048-7  0.96
1995 McRae BL, Vanderlugt CL, Dal Canto MC, Miller SD. Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis. The Journal of Experimental Medicine. 182: 75-85. PMID 7540658 DOI: 10.1084/jem.182.1.75  0.72
1994 Nicholson SM, Peterson JD, Miller SD, Wang K, Dal Canto MC, Melvold RW. BALB/c substrain differences in susceptibility to Theiler's murine encephalomyelitis virus-induced demyelinating disease. Journal of Neuroimmunology. 52: 19-24. PMID 8207118 DOI: 10.1016/0165-5728(94)90157-0  0.96
1994 Karpus WJ, Peterson JD, Miller SD. Anergy in vivo: down-regulation of antigen-specific CD4+ Th1 but not Th2 cytokine responses. International Immunology. 6: 721-30. PMID 8080842 DOI: 10.1093/intimm/6.5.721  0.96
1994 Pullen LC, Miller SD, Dal Canto MC, Van der Meide PH, Kim BS. Alteration in the level of interferon-gamma results in acceleration of Theiler's virus-induced demyelinating disease. Journal of Neuroimmunology. 55: 143-52. PMID 7829664 DOI: 10.1016/0165-5728(94)90004-3  0.4
1994 Miller SD, Karpus WJ. The immunopathogenesis and regulation of T-cell-mediated demyelinating diseases Trends in Immunology. 15: 356-361. DOI: 10.1016/0167-5699(94)90173-2  0.96
1993 Peterson JD, Karpus WJ, Clatch RJ, Miller SD. Split tolerance of Th1 and Th2 cells in tolerance to Theiler's murine encephalomyelitis virus. European Journal of Immunology. 23: 46-55. PMID 8419186 DOI: 10.1002/eji.1830230109  0.96
1993 Pullen LC, Miller SD, Dal Canto MC, Kim BS. Class I-deficient resistant mice intracerebrally inoculated with Theiler's virus show an increased T cell response to viral antigens and susceptibility to demyelination. European Journal of Immunology. 23: 2287-93. PMID 8370406 DOI: 10.1002/eji.1830230935  0.4
1992 McRae BL, Kennedy MK, Tan LJ, Dal Canto MC, Picha KS, Miller SD. Induction of active and adoptive relapsing experimental autoimmune encephalomyelitis (EAE) using an encephalitogenic epitope of proteolipid protein. Journal of Neuroimmunology. 38: 229-40. PMID 1376328 DOI: 10.1016/0165-5728(92)90016-E  0.4
1992 Miller SD, Tan LJ, Pope L, Mcrae BL, Karpus WJ. Antigen-specific tolerance as a therapy for experimental autoimmune encephalomyelitis International Reviews of Immunology. 9: 203-222. PMID 1285061 DOI: 10.3109/08830189209061791  0.96
1991 Miller SD, Tan LJ, Kennedy MK, Dal Canto MC. Specific immunoregulation of the induction and effector stages of relapsing EAE via neuroantigen-specific tolerance induction. Annals of the New York Academy of Sciences. 636: 79-94. PMID 1724364 DOI: 10.1111/j.1749-6632.1991.tb33440.x  0.4
1990 Clatch RJ, Miller SD, Metzner R, Dal Canto MC, Lipton HL. Monocytes/macrophages isolated from the mouse central nervous system contain infectious Theiler's murine encephalomyelitis virus (TMEV). Virology. 176: 244-54. PMID 2158691 DOI: 10.1016/0042-6822(90)90249-Q  0.96
1990 Peterson JD, Miller SD, Waltenbaugh C. Rapid biotin-avidin method for quantitation of antiviral antibody isotypes. Journal of Virological Methods. 27: 189-201. PMID 2156880 DOI: 10.1016/0166-0934(90)90135-3  0.96
1990 Miller SD, Gerety SJ, Kennedy MK, Peterson JD, Trotter JL, Tuohy VK, Waltenbaugh C, Dal Canto MC, Lipton HL. Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease. III. Failure of neuroantigen-specific immune tolerance to affect the clinical course of demyelination. Journal of Neuroimmunology. 26: 9-23. PMID 1688446 DOI: 10.1016/0165-5728(90)90115-4  0.96
1989 Peterson JD, Kim JY, Melvold RW, Miller SD, Waltenbaugh C. A rapid method for quantitation of antiviral antibodies. Journal of Immunological Methods. 119: 83-94. PMID 2540240 DOI: 10.1016/0022-1759(89)90384-0  0.96
1987 Clatch RJ, Melvold RW, Dal Canto MC, Miller SD, Lipton HL. The Theiler's murine encephalomyelitis virus (TMEV) model for multiple sclerosis shows a strong influence of the murine equivalents of HLA-A, B, and C. Journal of Neuroimmunology. 15: 121-35. PMID 3584435 DOI: 10.1016/0165-5728(87)90087-7  0.4
1987 Kennedy MK, Clatch RJ, Dal Canto MC, Trotter JL, Miller SD. Monoclonal antibody-induced inhibition of relapsing EAE in SJL/J mice correlates with inhibition of neuroantigen-specific cell-mediated immune responses. Journal of Neuroimmunology. 16: 345-64. PMID 2444626 DOI: 10.1016/0165-5728(87)90110-X  0.96
1986 Kennedy MK, Jenkins MK, Miller SD. Mechanisms of genetic control of immune responses - II. Nonresponsiveness in BALB/c GT-specific cell-mediated immune responses does not correlate with the absence of functional T cells or the induction of suppressor T cells Immunogenetics. 23: 292-301. PMID 2423450 DOI: 10.1007/BF00398791  0.96
1985 Miller SD, Jenkins MK. In vivo effects of GK1.5 (anti-L3T4a) monoclonal antibody on induction and expression of delayed-type hypersensitivity Cellular Immunology. 92: 414-426. PMID 2859929 DOI: 10.1016/0008-8749(85)90022-X  0.96
1984 Miller SD, Butler LD. T-Cell responses induced by the parenteral injection of antigen-modified syngeneic cells. III. Dissociation of primed cytolytic T-cell and efferent suppressor-T-cell activity following intravenous injection of trinitrophenol-modified syngeneic spleen cells Cellular Immunology. 86: 308-316. PMID 6234068 DOI: 10.1016/0008-8749(84)90385-X  0.96
1984 Jenkins MK, Lei HY, Waltenbaugh C, Miller SD. Immunoregulatory pathways in adult responder mice. I. Induction of GAT-specific tolerance and suppressor T cells for cellular and humoral responses Scandinavian Journal of Immunology. 19: 501-512. PMID 6204374 DOI: 10.1111/j.1365-3083.1984.tb00961.x  0.96
1980 Claman HN, Miller SD. Immunoregulation of contact sensitivity Journal of Investigative Dermatology. 74: 263-266. PMID 6446580 DOI: 10.1111/1523-1747.ep12543348  0.96
1979 Miller SD. Suppressor T-cell mechanisms in contact sensitivity. III. Apparent non-major histocompatibility complex restriction is a result of multiple sets of major histocompatibility complex-specific suppressor T cells induced by syngeneic 2,4-dinitrophenyl-modified lymphoid cells Journal of Experimental Medicine. 150: 676-692. PMID 314489 DOI: 10.1084/jem.150.3.676  0.96
Show low-probability matches.